ATE507309T1 - Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung - Google Patents

Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Info

Publication number
ATE507309T1
ATE507309T1 AT09151217T AT09151217T ATE507309T1 AT E507309 T1 ATE507309 T1 AT E507309T1 AT 09151217 T AT09151217 T AT 09151217T AT 09151217 T AT09151217 T AT 09151217T AT E507309 T1 ATE507309 T1 AT E507309T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
oral squamous
suppressing
carcinoma
detecting
Prior art date
Application number
AT09151217T
Other languages
English (en)
Inventor
Johji Inazawa
Ken-Ichi Kozaki
Issei Imoto
Original Assignee
Fujifilm Corp
Nat Univ Corp Tokyo Med & Dent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Nat Univ Corp Tokyo Med & Dent filed Critical Fujifilm Corp
Application granted granted Critical
Publication of ATE507309T1 publication Critical patent/ATE507309T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT09151217T 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung ATE507309T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008012256A JP5116026B2 (ja) 2008-01-23 2008-01-23 癌の検出方法および癌抑制剤

Publications (1)

Publication Number Publication Date
ATE507309T1 true ATE507309T1 (de) 2011-05-15

Family

ID=40748687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09151217T ATE507309T1 (de) 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Country Status (5)

Country Link
US (2) US20090202624A1 (de)
EP (1) EP2088208B1 (de)
JP (1) JP5116026B2 (de)
AT (1) ATE507309T1 (de)
DE (1) DE602009001116D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119698A1 (ja) * 2009-04-16 2010-10-21 学校法人 慶應義塾 頭頸部腫瘍増殖抑制剤
EP2283846A1 (de) * 2009-08-12 2011-02-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. miRNA-Verbindungen zur Behandlung von Prostatakarzinomen
US8921333B2 (en) 2009-10-01 2014-12-30 National Cancer Center Therapeutic agent for tumor
WO2011067346A1 (en) * 2009-12-04 2011-06-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for determining the efficiency of a cancer treatment
CA2804271A1 (en) 2010-07-08 2012-01-12 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for diabetes
EP2596136B1 (de) * 2011-05-06 2014-07-16 Zhongshan Hospital Fudan University Marker aus plasma-mikro-rna und neues verfahren zur diagnostik des hepatozellulären karzinoms
JPWO2013038737A1 (ja) 2011-09-16 2015-03-23 Lsipファンド運営合同会社 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ
WO2013071502A1 (en) * 2011-11-17 2013-05-23 Genedia Biotech Co Ltd Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes
ES2886147T3 (es) * 2011-12-22 2021-12-16 Interna Tech B V MiARN para el tratamiento del cáncer de cabeza y de cuello
DK2963125T3 (da) 2013-02-15 2020-10-12 Univ Nat Corp Tokyo Medical & Dental Terapeutisk middel til behandling af en cancer, hvor NRF2 er stabiliseret
WO2017079571A1 (en) * 2015-11-05 2017-05-11 Arphion Diagnostics Process for the indentication of patients at risk for oscc
EP4265725A3 (de) * 2017-11-09 2023-12-27 Purmx Therapeutics, Inc. Pharmazeutische zusammensetzung enthaltend mirna-3140 zur behandlung von krebs
WO2019117270A1 (ja) * 2017-12-13 2019-06-20 国立大学法人広島大学 頭頸部がんの検出を補助する方法
US20220296629A1 (en) * 2019-06-03 2022-09-22 Carmel Haifa University Economic Corporation Ltd. Human head and neck cancer treatment
CN114207113A (zh) 2019-08-09 2022-03-18 宇部兴产株式会社 外泌体的产生方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554818A1 (en) 2004-02-09 2005-08-25 Thomas Jefferson University Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
CA2857878A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
EP2484782B1 (de) * 2006-01-05 2015-11-18 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von soliden Krebs
EP2502630B1 (de) * 2006-01-05 2015-03-11 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose, Prognose und Behandlung von Lungenkrebs
WO2007126150A1 (ja) * 2006-04-27 2007-11-08 National University Corporation Nagoya University 癌の新規治療用組成物
EP2455493B1 (de) * 2006-07-13 2014-01-08 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von Krankheiten im Zusammenhang mit dem Dickdarm

Also Published As

Publication number Publication date
US20110076768A1 (en) 2011-03-31
US8183223B2 (en) 2012-05-22
EP2088208B1 (de) 2011-04-27
JP5116026B2 (ja) 2013-01-09
DE602009001116D1 (de) 2011-06-09
JP2009171876A (ja) 2009-08-06
US20090202624A1 (en) 2009-08-13
EP2088208A1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
DE602007002090D1 (de) Verfahren zur Erkennung von anaplastischem Schilddrüsenkrebs, und Verfahren zur seiner Unterdrückung
EP3862439A3 (de) Leberkrebsdetektionskit oder -vorrichtung und detektionsverfahren
EP4461824A3 (de) Kit oder vorrichtung zur erkennung von gallengangkrebs und nachweisverfahren
EP2262911A4 (de) Zusammensetzungen, verfahren und kits mit synthetischen sonden zum nachweis der anwesenheit einer target-nukleinsäure
DK3581662T3 (da) Sammensætninger og fremgangsmåder til detektering og identificering af nukleinsyresekvenser i biologiske prøver
WO2011055916A3 (ko) 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법
WO2011141908A3 (en) Fluids testing apparatus and methods of use
EP2402423A4 (de) An monoterpenbestandteilen reiches ätherisches öl, verfahren zu seiner herstellung und verfahren zur sanierung von umweltschadstoffen anhand des ätherischen öls
EP2547809A4 (de) Verfahren, sondensets und kits zur erkennung der zerstörung von tumorunterdrückergenen durch in-situ-fluoreszenz-hybridisierung
WO2008054556A3 (en) Methods and compositions for detection of a target nucleic acid sequence
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
EP2518158A4 (de) Marker für pankreaskarzinom, nachweisverfahren, kits und biochips dafür
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
WO2013102108A3 (en) Nucleic acid hybridization probes
MY160850A (en) Polymer-bonded perylene dyes and compositions containing same
AT10182U3 (de) Verfahren zur überwachung von leistungsprüfständen, sowie leistungsprüfstand
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
MX363880B (es) Sondas, cebadores cooperativos y aplicaciones de ellos.
WO2019094780A3 (en) Non-coding rna for detection of cancer
EP2504348A4 (de) Verfahren, reagenzien und kits für den nachweis von nukleinsäuremolekülen
ATE544070T1 (de) Verfahren zum nachweis von tumorspezifischen fusionsproteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties